Lilly and Novo’s brand values soar as GLP-1 drugs raise their profiles

Barnstorming GLP-1 drugs have sent Eli Lilly and Novo Nordisk rocketing up the list of the most valuable pharma brands. | Barnstorming GLP-1 drugs have sent Eli Lilly and Novo Nordisk rocketing up the list of the most valuable pharma brands. The leading weight-loss players were the two big winners in the latest report by Brand Finance, which found the value of the two brands jumped by more than 50% over the past year.

Leave a Reply

Your email address will not be published. Required fields are marked *